Analysis of the clinical characteristics of lamotrigine-induced haemophagocytic lymphohistiocytosis.

Chunjiang WangZhiqiang FanYang HeWeijin FangWei SunZuojun Li

Published in: Journal of clinical pharmacy and therapeutics (2022)

Hemophagocytic lymphohistiocytosis is a potentially serious adverse reaction to lamotrigine (LTG). Patients should be informed that if they experience any symptoms of HLH while taking lamotrigine, they should immediately seek medical attention.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
healthcare
peritoneal dialysis
working memory
high glucose
physical activity
sleep quality